MORE►
Caris
[Courtesy: Caris Life Sciences]
Irving’s Caris Life Sciences Raises $830M to Grow Its Precision Medicine Platform for Cancer Care
by Alex Edwards | May 12, 2021
Now valued at more than $7.8 billion, Caris specializes in AI-powered genetic sequencing for personalized cancer treatments. The massive capital raise follows a $310 million round in October and boosts the 13-year-old company's total funding to about $1.3 billion.
by Alex Edwards |
Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
by Alex Edwards |
Aug 20, 2019
The Caris Life Sciences Corporate Park in Irving will increase R&D capabilities with a state-of-the-art precision medicine laboratory, create more than 500 jobs in the region, and help Caris continue to "reinvent cancer care."
MORE►
by Payton Potter |
May 2, 2019
Using a patient's molecular makeup, Caris and Pharmatech aim to find the perfect clinical trial for each cancer patient—and enroll them in as little as 10 days.
MORE►
